An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects
- PMID: 23040494
- PMCID: PMC3484504
- DOI: 10.1016/j.ajhg.2012.08.017
An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects
Abstract
About half of people with trisomy 21 have a congenital heart defect (CHD), whereas the remainder have a structurally normal heart, demonstrating that trisomy 21 is a significant risk factor but is not causal for abnormal heart development. Atrioventricular septal defects (AVSD) are the most commonly occurring heart defects in Down syndrome (DS), and ∼65% of all AVSD is associated with DS. We used a candidate-gene approach among individuals with DS and complete AVSD (cases = 141) and DS with no CHD (controls = 141) to determine whether rare genetic variants in genes involved in atrioventricular valvuloseptal morphogenesis contribute to AVSD in this sensitized population. We found a significant excess (p < 0.0001) of variants predicted to be deleterious in cases compared to controls. At the most stringent level of filtering, we found potentially damaging variants in nearly 20% of cases but fewer than 3% of controls. The variants with the highest probability of being damaging in cases only were found in six genes: COL6A1, COL6A2, CRELD1, FBLN2, FRZB, and GATA5. Several of the case-specific variants were recurrent in unrelated individuals, occurring in 10% of cases studied. No variants with an equal probability of being damaging were found in controls, demonstrating a highly specific association with AVSD. Of note, all of these genes are in the VEGF-A pathway, even though the candidate genes analyzed in this study represented numerous biochemical and developmental pathways, suggesting that rare variants in the VEGF-A pathway might contribute to the genetic underpinnings of AVSD in humans.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002;39:1890–1900. - PubMed
-
- Srivastava D., Olson E.N. A genetic blueprint for cardiac development. Nature. 2000;407:221–226. - PubMed
-
- Posch M.G., Perrot A., Schmitt K., Mittelhaus S., Esenwein E.M., Stiller B., Geier C., Dietz R., Gessner R., Ozcelik C., Berger F. Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am. J. Med. Genet. A. 2008;146A:251–253. - PubMed
-
- Esposito G., Butler T.L., Blue G.M., Cole A.D., Sholler G.F., Kirk E.P., Grossfeld P., Perryman B.M., Harvey R.P., Winlaw D.S. Somatic mutations in NKX2–5, GATA4, and HAND1 are not a common cause of tetralogy of Fallot or hypoplastic left heart. Am. J. Med. Genet. A. 2011;155A:2416–2421. - PubMed
-
- Liu H., Dai L., Mao M., Wang X., Hua Y., Xie L. Absence of association between length variation of an intronic region in the NFATC1 gene and congenital heart defects in a Han Chinese population. DNA Cell Biol. 2012;31:88–91. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR00039/RR/NCRR NIH HHS/United States
- UL1RR024140/RR/NCRR NIH HHS/United States
- UL1 TR000128/TR/NCATS NIH HHS/United States
- N01-HV-48194/HV/NHLBI NIH HHS/United States
- N01 HV048194/HL/NHLBI NIH HHS/United States
- T32 HL094294/HL/NHLBI NIH HHS/United States
- F32 HD046337/HD/NICHD NIH HHS/United States
- R01 LM009722/LM/NLM NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- T32 GM008490/GM/NIGMS NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- M01 RR000039/RR/NCRR NIH HHS/United States
- U54 HG004028/HG/NHGRI NIH HHS/United States
- UL1 RR025008/RR/NCRR NIH HHS/United States
- R01HD083300/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
